Tower Research Capital (TRC)’s Applied UV, Inc. Common Stock AUVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,962
Closed -$7.39K 6190
2024
Q1
$7.39K Buy
4,962
+4,276
+623% +$9.07K ﹤0.01% 4212
2023
Q4
$1.62K Buy
686
+503
+275% +$2.39K ﹤0.01% 5353
2023
Q3
$1.48K Buy
183
+23
+14% +$385 ﹤0.01% 5323
2023
Q2
$3.72K Buy
160
+93
+139% +$5.87K ﹤0.01% 5032
2023
Q1
$7K Buy
67
+27
+68% +$3.58K ﹤0.01% 4799
2022
Q4
$4K Buy
40
+20
+100% +$2.6K ﹤0.01% 5113
2022
Q3
$3K Buy
+20
New +$4.5K ﹤0.01% 5464
2022
Q2
Sell
-32
Closed -$6K 6740
2022
Q1
$6K Buy
32
+24
+300% +$5.36K ﹤0.01% 4966
2021
Q4
$3K Buy
8
+2
+33% +$1.24K ﹤0.01% 5529
2021
Q3
$5K Sell
6
-35
-85% -$33.6K ﹤0.01% 4907
2021
Q2
$50K Buy
+41
New +$47.4K ﹤0.01% 3032
2021
Q1
Sell
-41
Closed -$23K 5847
2020
Q4
$23K Buy
+41
New +$29.7K ﹤0.01% 3790

Tower Research Capital (TRC)'s AUVI Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Applied UV, Inc. Common Stock (AUVI) in Q2 2024, closing a stake of 4,962 shares — an estimated $7.39K sold.

Tower Research Capital (TRC) first reported a position in AUVI in Q4 2020 and held it in 12 quarters. The position peaked at $50K in Q2 2021. 1 fund tracked by Wall St. Rank holds AUVI as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Applied UV, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,962 Applied UV, Inc. Common Stock shares in Q2 2024, an estimated $7.39K.
  • Tower Research Capital (TRC) first reported a position in Applied UV, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Applied UV, Inc. Common Stock position peaked at $50K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Applied UV, Inc. Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.